Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
==Multi-agent regimen== | ==Multi-agent regimen== | ||
| − | = | + | =Named classes= |
| + | All classes in this category have at least one named agent or class of agents. | ||
==Alkylator-based regimen== | ==Alkylator-based regimen== | ||
==Anthracycline-based regimen== | ==Anthracycline-based regimen== | ||
Revision as of 12:24, 13 December 2022
The purpose of this page is to define regimen classes that will be used in the HemOnc ontology; it is not for other purposes at this time.
Generic classes
Allogeneic HSCT
Chemoradiotherapy
Fluoropyrimidine-based chemoradiotherapy
5-FU-based chemoradiotherapy
Chemotherapy
Biochemotherapy
High-dose chemotherapy with auto HSCT
Intensive chemotherapy
Endocrine therapy
Radiotherapy
Single-agent regimen
Single-agent cytotoxic chemotherapy
Single-agent hormonotherapy
Single-agent immunotherapy
Single-agent targeted therapy
Multi-agent regimen
Named classes
All classes in this category have at least one named agent or class of agents.